⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8588404 | 1.00 | — | — | |
| SCHEMBL11329298 | 0.91 | FAAH (0.48) | — | |
| SCHEMBL5162195 | 0.91 | FAAH (0.48) | — | |
| SCHEMBL7029383 | 0.91 | FAAH (0.48) | — | |
| SCHEMBL4372342 | 0.91 | FAAH (0.48) | — | |
| SCHEMBL11706913 | 0.91 | FAAH (0.48) | — | |
| SCHEMBL6320419 | 0.91 | FAAH (0.48) | — | |
| SCHEMBL11612560 | 0.91 | FAAH (0.48) | — | |
| SCHEMBL11705528 | 0.91 | FAAH (0.48) | — | |
| SCHEMBL11329294 | 0.91 | FAAH (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681476-B1 | TRANSDERMAL FORMULATIONS | TYME INC (US) | 2022-09-14 | — | — | EP | claimed |
| US-20200405680-A1 | TRANSDERMAL FORMULATIONS | TYME, INC. (US) | 2020-12-31 | — | — | US | claimed |
| EP-3681476-A1 | TRANSDERMAL FORMULATIONS | Tyme, Inc. (US) | 2020-07-22 | — | — | EP | claimed |
| CN-111328278-A | Transdermal preparation | 迪美公司 | 2020-06-23 | — | — | CN | claimed |
| WO-2019055747-A1 | TRANSDERMAL FORMULATIONS | TYME, INC. (US) | 2019-03-21 | — | — | WO | claimed |
| CN-116096824-B | Modified natural product and use thereof | 大金工业株式会社 | 2025-04-29 | — | — | CN | disclosed |
| EP-4219638-A1 | MODIFIED NATURAL MATERIAL AND USE THEREOF | Daikin Industries, Ltd. (JP) | 2023-08-02 | — | — | EP | disclosed |
| US-20230220217-A1 | MODIFIED NATURAL MATERIAL AND USE THEREOF | DAIKIN INDUSTRIES, LTD. (JP) | 2023-07-13 | — | — | US | disclosed |
| CN-116096824-A | Modified natural product and use thereof | 大金工业株式会社 | 2023-05-09 | — | — | CN | disclosed |
| EP-3681476-B1 | TRANSDERMAL FORMULATIONS | TYME INC (US) | 2022-09-14 | — | — | EP | disclosed |
| CN-109563376-B | Two-liquid mixed adhesive | 株式会社E-TEC | 2022-07-05 | — | — | CN | disclosed |
| WO-2022065382-A1 | MODIFIED NATURAL MATERIAL AND USE THEREOF | ダイキン工業株式会社 | 2022-03-31 | — | — | WO | disclosed |
| US-20200347275-A1 | TWO-COMPONENT ADHESIVE | EMULSION TECHNOLOGY CO., LTD. (JP) | 2020-11-05 | — | — | US | disclosed |
| EP-3681476-A1 | TRANSDERMAL FORMULATIONS | Tyme, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| CN-111328278-A | Transdermal preparation | 迪美公司 | 2020-06-23 | — | — | CN | disclosed |
| WO-2019055747-A1 | TRANSDERMAL FORMULATIONS | TYME, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| US-9458251-B2 | Cellulose resin and process for producing the same | NEC CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9181351-B2 | Cellulose resin and process for producing the same | NEC CORPORATION (JP) | 2015-11-10 | — | — | US | disclosed |
| US-20140024824-A1 | CELLULOSE RESIN AND PROCESS FOR PRODUCING THE SAME | NEC CORPORATION (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20140018530-A1 | CELLULOSE RESIN AND PROCESS FOR PRODUCING THE SAME | NEC CORPORATION (JP) | 2014-01-16 | — | — | US | disclosed |